Diaz-Llopis Manuel, Salom David, García-Delpech Salvador, Udaondo Patricia, Millan Jose Maria, Arevalo J Fernando
Department of Ophthalmology, La Fe University Hospital of Valencia, Valencia, Spain.
Clin Ophthalmol. 2010 May 6;4:411-6. doi: 10.2147/opth.s10005.
To evaluate the efficacy and safety of the pars plana clip (PPC) in the Ahmed valve tube inserted via the pars plana in patients with secondary refractory glaucomas.
Prospective and interventional case series that included 10 patients with secondary refractory glaucoma. The pars plana vitrectomy and the implant of the modified tube were performed during the same surgery. Control of intraocular pressure (IOP) and the development of intra- and postoperative complications were evaluated during the follow-up.
Follow-up time was twelve months in all the patients. Control of IOP was achieved in 90% of patients, and 70% needed no antiglaucoma treatment. The complications that occurred were transient hypotony in three cases, choroidal detachment in two cases, and one case of intraocular hemorrhage. No case of tube extrusion or tube kink was observed.
Our data suggests that implantation of the Ahmed tube modified with the PPC via the pars plana is safe and effective in patients with secondary refractory glaucomas.
评估经睫状体平坦部插入艾哈迈德人工房水引流阀管时使用睫状体平坦部夹（PPC）治疗继发性难治性青光眼患者的疗效及安全性。
前瞻性干预性病例系列研究，纳入10例继发性难治性青光眼患者。在同一次手术中进行睫状体平坦部玻璃体切除术及改良管植入术。随访期间评估眼压控制情况及术中、术后并发症的发生情况。
所有患者随访时间均为12个月。90%的患者眼压得到控制，70%的患者无需抗青光眼治疗。发生的并发症包括3例短暂性低眼压、2例脉络膜脱离和1例眼内出血。未观察到引流管脱出或引流管扭结的情况。
我们的数据表明，经睫状体平坦部植入用PPC改良的艾哈迈德引流管治疗继发性难治性青光眼患者是安全有效的。
Zotero 插件
